英文论文

1: Yan X, Guo ZX, Liu XP, Feng YJ, Zhao YJ, Liu TZ, Li S. Four novel biomarkers for bladder cancer identified by weighted gene coexpression network analysis. J Cell Physiol. 2019 Mar 29. doi: 10.1002/jcp.28546.

2: Cheng S, Qian K, Wang Y, Wang G, Liu X, Xiao Y, Wang X. PPARγ inhibition regulates the cell cycle, proliferation and motility of bladder cancer cells. J Cell Mol Med. 2019 Mar 25. doi: 10.1111/jcmm.14280. 

3: Yan Y, Chen Z, Xiao Y, Wang X, Qian K. Long non-coding RNA SNHG6 is upregulated in prostate cancer and predicts poor prognosis. Mol Biol Rep. 2019 Mar 25. doi: 10.1007/s11033-019-04723-9. 

4: Cui Q, Kong D, Li Z, Wang K, Zhang D, Tang J, Liao X, Yuan Q, Gong Y, Wu G. Parathyroid autotransplantation at a novel site for better evaluation of the grafted gland function: study protocol for a prospective, randomized controlled trial. Trials. 2019 Jan 31;20(1):96. doi: 10.1186/s13063-019-3195-9. 

5: Wei X, Ma H, Liu R, Zhao Y. Comparing the effectiveness of three scoring systems in predicting adult patient outcomes in the emergency department. Medicine (Baltimore). 2019 Feb;98(5):e14289. doi: 10.1097/MD.0000000000014289.

6: Meng XY, Shi MJ, Zeng ZH, Chen C, Liu TZ, Wu QJ, Li S, Li S. The Role of COL5A2 in Patients With Muscle-Invasive Bladder Cancer: A Bioinformatics Analysis of Public Datasets Involving 787 Subjects and 29 Cell Lines. Front Oncol. 2019 Jan 15;8:659. doi: 10.3389/fonc.2018.00659.

7: Wang F, Luo Y, Tian X, Ma S, Sun Y, You C, Gong Y, Xie C. Impact of Radiotherapy Concurrent with Anti-PD-1 Therapy on the Lung Tissue of Tumor-Bearing Mice. Radiat Res. 2019 Mar;191(3):271-277. doi: 10.1667/RR15182.1. 

8: Chen S, Wang L, Qian K, Jiang W, Deng H, Zhou Q, Wang G, Liu X, Wu CL, Xiao Y, Wang X. Establishing a prediction model for prostate cancer bone metastasis. Int J Biol Sci. 2019 Jan 1;15(1):208-220. doi: 10.7150/ijbs.27537. 

9: Li S, Meng XY, Maman STD, Xiao YN, Li S. Lenalidomide and Low Dose Dexamethasone Plus Elotuzumab or Carfilzomib for Relapsed or Refractory Multiple Myeloma: A Comparison of Progression-Free Survival with Reconstructed Individual Participant Data. Biomed Res Int. 2018 Dec 16;2018:9057823. doi:10.1155/2018/9057823. 

10: Wang L, Chen S, Luo Y, Yuan L, Peng T, Qian K, Liu X, Xiao Y, Wang X. Identification of several cell cycle relevant genes highly correlated with the progression and prognosis of human bladder urothelial tumor. J Cell Physiol. 2019 Jan 7. doi: 10.1002/jcp.28023. 

11: Tian X, Wang F, Luo Y, Ma S, Zhang N, Sun Y, You C, Tang G, Li S, Gong Y, Xie C. Protective Role of Nuclear Factor-Erythroid 2-Related Factor 2 Against Radiation-Induced Lung Injury and Inflammation. Front Oncol. 2018 Nov 23;8:542. doi: 10.3389/fonc.2018.00542. 

12: Wang H, Lin X, Luo Y, Sun S, Tian X, Sun Y, Zhang S, Chen J, Zhang J, Liu X, Liu H, Gong Y, Xie C. α-PD-L1 mAb enhances the abscopal effect of hypo-fractionated radiation by attenuating PD-L1 expression and inducing CD8(+) T-cell infiltration. Immunotherapy. 2019 Feb;11(2):101-118. doi: 10.2217/imt-2018-0049. 

13: Ge Q, Lu M, Ju L, Qian K, Wang G, Wu CL, Liu X, Xiao Y, Wang X. miR-4324-RACGAP1-STAT3-ESR1 feedback loop inhibits proliferation and metastasis of bladder cancer. Int J Cancer. 2018 Dec 3. doi: 10.1002/ijc.32036. 

14: Wang Y, Chen L, Wang G, Cheng S, Qian K, Liu X, Wu CL, Xiao Y, Wang X. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis. J Cell Physiol. 2019 Jul;234(7):10225-10237. doi: 10.1002/jcp.27692.

15: Chen L, Luo Y, Wang G, Qian K, Qian G, Wu CL, Dan HC, Wang X, Xiao Y. Prognostic value of a gene signature in clear cell renal cell carcinoma. J Cell Physiol. 2019 Jul;234(7):10324-10335. doi: 10.1002/jcp.27700. 

16: Xiong Y, Yuan L, Chen L, Zhu Y, Zhang S, Liu X, Xiao Y, Wang X. Identifying a Novel Biomarker TOP2A of Clear Cell Renal Cell Carcinoma (ccRCC) Associated with Smoking by Co-Expression Network Analysis. J Cancer. 2018 Oct 10;9(21):3912-3922. doi: 10.7150/jca.25900. 

17: Lu M, Ge Q, Wang G, Luo Y, Wang X, Jiang W, Liu X, Wu CL, Xiao Y, Wang X. CIRBP is a novel oncogene in human bladder cancer inducing expression of HIF-1α. Cell Death Dis. 2018 Oct 12;9(10):1046. doi: 10.1038/s41419-018-1109-5. 

18: Tang J, Kong D, Cui Q, Wang K, Zhang D, Gong Y, Wu G. Prognostic Genes of Breast Cancer Identified by Gene Co-expression Network Analysis. Front Oncol. 2018 Sep 11;8:374. doi: 10.3389/fonc.2018.00374. 

19: Yuan L, Qian G, Chen L, Wu CL, Dan HC, Xiao Y, Wang X. Co-expression Network Analysis of Biomarkers for Adrenocortical Carcinoma. Front Genet. 2018 Aug 15;9:328. doi: 10.3389/fgene.2018.00328. 

20: Bi Y, Chen S, Jiang J, Yao J, Wang G, Zhou Q, Li S. CDCA8 expression and its clinical relevance in patients with bladder cancer. Medicine (Baltimore). 2018 Aug;97(34):e11899. doi: 10.1097/MD.0000000000011899. 

21: You C, Zhang S, Sun Y, Zhang S, Tang G, Tang F, Liu X, Xiao Y, Zhang J, Gong Y, Xie C. β-catenin decreases acquired TRAIL resistance in non-small-cell lung cancer cells by regulating the redistribution of death receptors. Int J Oncol. 2018 Nov;53(5):2258-2268. doi: 10.3892/ijo.2018.4529.

22: Zhang D, Tang J, Kong D, Cui Q, Wang K, Gong Y, Wu G. Impact of Gender and Age on the Prognosis of Differentiated Thyroid Carcinoma: a Retrospective Analysis Based on SEER. Horm Cancer. 2018 Oct;9(5):361-370. doi: 10.1007/s12672-018-0340-y.

23: Tang J, Kong D, Cui Q, Wang K, Zhang D, Liao X, Gong Y, Wu G. The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER. Onco Targets Ther. 2018 Jun 19;11:3551-3560. doi: 10.2147/OTT.S160752. 

24: Wang J, Yuan L, Liu X, Wang G, Zhu Y, Qian K, Xiao Y, Wang X. Bioinformatics and functional analyses of key genes and pathways in human clear cell renal cell carcinoma. Oncol Lett. 2018 Jun;15(6):9133-9141. doi: 10.3892/ol.2018.8473.

25: Tang J, Kong D, Cui Q, Wang K, Zhang D, Yuan Q, Liao X, Gong Y, Wu G. Bioinformatic analysis and identification of potential prognostic microRNAs and mRNAs in thyroid cancer. PeerJ. 2018 May 4;6:e4674. doi: 10.7717/peerj.4674.

26: Chen L, Yuan L, Qian K, Qian G, Zhu Y, Wu CL, Dan HC, Xiao Y, Wang X. Identification of Biomarkers Associated With Pathological Stage and Prognosis of Clear Cell Renal Cell Carcinoma by Co-expression Network Analysis. Front Physiol. 2018 Apr 18;9:399. doi: 10.3389/fphys.2018.00399. 

27: Yuan L, Zeng G, Chen L, Wang G, Wang X, Cao X, Lu M, Liu X, Qian G, Xiao Y, Wang X. Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis. Int J Biol Sci. 2018 Feb 12;14(3):266-279. doi: 10.7150/ijbs.23574. eCollection 2018.

28: Tang J, Kong D, Cui Q, Wang K, Zhang D, Liao X, Gong Y, Wu G. Racial disparities of differentiated thyroid carcinoma: clinical behavior, treatments, and long-term outcomes. World J Surg Oncol. 2018 Mar 5;16(1):45. doi: 10.1186/s12957-018-1340-7. 

29: You C, Sun Y, Zhang S, Tang G, Zhang N, Li C, Tian X, Ma S, Luo Y, Sun W, Wang F, Liu X, Xiao Y, Gong Y, Zhang J, Xie C. Trichosanthin enhances sensitivity of non-small cell lung cancer (NSCLC) TRAIL-resistance cells. Int J Biol Sci. 2018 Feb 9;14(2):217-227. doi: 10.7150/ijbs.22811. 

30: Yan Y, Chen S, Chen Z, Pei X, Zhou J, Xiao Y, Wang X. The applied value of medical history, physical examination, colour-Doppler ultrasonography and testis scintigraphy in the differential diagnosis of acute scrotum. Andrologia. 2018 Feb 20. doi: 10.1111/and.12973. 

31: Sun Y, Miao H, Ma S, Zhang L, You C, Tang F, Yang C, Tian X, Wang F, Luo Y, Lin X, Wang H, Li C, Li Z, Yu H, Liu X, Xiao Y, Gong Y, Zhang J, Quan H, Xie C. FePt-Cys nanoparticles induce ROS-dependent cell toxicity, and enhance chemo-radiation sensitivity of NSCLC cells in vivo and in vitro. Cancer Lett. 2018 Apr 1;418:27-40. doi: 10.1016/j.canlet.2018.01.024. 

32: Li S, Liu X, Liu T, Meng X, Yin X, Fang C, Huang D, Cao Y, Weng H, Zeng X, Wang X. Identification of Biomarkers Correlated with the TNM Staging and Overall  Survival of Patients with Bladder Cancer. Front Physiol. 2017 Nov 28;8:947. doi: 10.3389/fphys.2017.00947. 

33: Ye R, Wei B, Li S, Liu W, Liu J, Qiu L, Wu X, Zhao Z, Li J. Expression of miR-195 is associated with chemotherapy sensitivity of cisplatin and clinical prognosis in gastric cancer. Oncotarget. 2017 Oct 19;8(57):97260-97272. doi: 10.18632/oncotarget.21919. 

34: Chen L, Yuan L, Wang Y, Wang G, Zhu Y, Cao R, Qian G, Xie C, Liu X, Xiao Y, Wang X. Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma. Int J Biol Sci. 2017 Nov 1;13(11):1361-1372. doi: 10.7150/ijbs.21657. 

35: Yuan L, Chen L, Qian K, Wang G, Lu M, Qian G, Cao X, Jiang W, Xiao Y, Wang X. A novel correlation between ATP5A1 gene expression and progression of human clear cell renal cell carcinoma identified by co‑expression analysis. Oncol Rep. 2018 Feb;39(2):525-536. doi: 10.3892/or.2017.6132. 

36: Cao R, Wang G, Qian K, Chen L, Ju L, Qian G, Wu CL, Dan HC, Jiang W, Wu M, Xiao Y, Wang X. TM4SF1 regulates apoptosis, cell cycle and ROS metabolism via the PPARγ-SIRT1 feedback loop in human bladder cancer cells. Cancer Lett. 2018 Feb 1;414:278-293. doi: 10.1016/j.canlet.2017.11.015. 

37: Yuan L, Chen L, Qian K, Qian G, Wu CL, Wang X, Xiao Y. Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC). Genom Data. 2017 Nov 4;14:132-140. doi: 10.1016/j.gdata.2017.10.006.

38: Hu Q, Wang G, Peng J, Qian G, Jiang W, Xie C, Xiao Y, Wang X. Knockdown of SIRT1 Suppresses Bladder Cancer Cell Proliferation and Migration and Induces Cell Cycle Arrest and Antioxidant Response through FOXO3a-Mediated Pathways. Biomed Res Int. 2017;2017:3781904. doi: 10.1155/2017/3781904. 

39: Yang X, Gong Y, He Q, Licht JD, Liaw L, Friesel RE. Loss of Spry1 attenuates vascular smooth muscle proliferation by impairing mitogen-mediated changes in cell cycle regulatory circuits. J Cell Biochem. 2018 Apr;119(4):3267-3279. doi: 10.1002/jcb.26486. 

40: Yuan L, Shu B, Chen L, Qian K, Wang Y, Qian G, Zhu Y, Cao X, Xie C, Xiao Y, Wang X. Overexpression of COL3A1 confers a poor prognosis in human bladder cancer identified by co-expression analysis. Oncotarget. 2017 Jul 28;8(41):70508-70520. doi: 10.18632/oncotarget.19733. 

41: Zhou Y, Miao J, Wu H, Tang H, Kuang J, Zhou X, Peng Y, Hu D, Shi D, Deng W, Cao X, Zhao C, Xie C. PD-1 and PD-L1 expression in 132 recurrent nasopharyngeal carcinoma: the correlation with anemia and outcomes. Oncotarget. 2017 Apr 19;8(31):51210-51223. doi: 10.18632/oncotarget.17214.

42: Cao R, Wang G, Qian K, Chen L, Qian G, Xie C, Dan HC, Jiang W, Wu M, Wu CL, Xiao Y, Wang X. Silencing of HJURP induces dysregulation of cell cycle and ROS metabolism in bladder cancer cells via PPARγ-SIRT1 feedback loop. J Cancer. 2017 Jul 20;8(12):2282-2295. doi: 10.7150/jca.19967.

中文论文

1: 钱开宇, 朱源, 曹馨月, 肖宇. 加强伦理委员会建设，促进生物样本库发展【J】. 转化医学杂志, 2018,7(01):14-16.

2: 吴曼丽, 唐孝梅, 朱源, 钱开宇. 医院型样本库微信公众号运营情况调查与分析【J】. 转化医学杂志, 2018,7(6):341-345.

3: 李洁莉, 刘尚勤, 阮晓岚, 熊亚芬, 刘小平, 孟详喻, 李胜. 应用病友交流会对老年多发性骨髓瘤患者行延续护理的效果【J】. 护理管理杂志，2018,18(09):670-673.

4: 晏鑫, 郭梓鑫, 袁佳仪, 冯雨嘉, 李洁莉, 李胜. TPX2基因表达对膀胱癌患者预后的影响【J】. 肿瘤代谢与营养电子杂志,  2018,5(03):292-296.

5: 杜国伟, 晏鑫, 郭梓鑫, 蒋佳志, 黄凯, 李胜, 刘同族.  IQGAP3基因表达对膀胱癌患者临床病理和预后的影响【J】. 现代泌尿外科杂志，2018,5(03):292-296.

6: 郭梓鑫, 晏鑫, 李胜, 刘同族, 孟详喻, 黄静宇. 基于GEO数据库分析AURKB在膀胱癌中的表达及其临床意义【J】. 临床肿瘤学杂志，2018,23(08):711-715.

7: 毕娅琼, 陈松, 蒋佳志, 石宏杰, 李胜.  CDCA8基因表达与膀胱癌患者临床病理和预后的相关性【J】. 武警医学，2018,29(08):750-754.

8: 曾俊杰, 邓巧玲, 李胜, 陈松. 高b值DWI联合DCE-MRI对前列腺癌的诊断价值【J】. 中国医刊, 2018,53(08):911-915.

9: 何恒晶, 李洁莉, 晏鑫, 李晓凤, 李胜, 周强, 徐畅. CDCA3基因表达对膀胱癌患者临床病理和预后的影响【J】. 华南国防医学杂志, 2018,32(03):157-160.

10: 李洁莉, 李胜, 徐畅, 张超, 黄静宇, 阮晓岚, 李卓. Rayyan：一种新型在线文献管理软件在系统评价中的应用【J】. 中国循证心血管医学杂志, 2018,10(03):265-268.

11: 晏鑫, 郭梓鑫, 袁佳仪, 蒋佳志, 毕娅琼, 李洁莉, 李胜. 使用GEO数据集分析CENPF在膀胱癌中的表达及临床意义【J】. 现代泌尿生殖肿瘤杂志, 2017,9(06):338-342.

12: 张维欣, 熊莺, 徐畅, 贾鹏丽, 刘玉, 张超, 李胜. 中文期刊发表的剂量-反应Meta分析方法学质量及报告质量现状【J】. 中国循证心血管医学杂志, 2017,9(11):1300-1304.

13: 李胜, 邓巧玲, 阮晓岚, 刘小平, 黄静宇, 孟详喻. 红花黄色素注射液治疗脑梗死疗效及安全性的系统评价【J】. 武警医学, 2017,28(11):1111-1117.

14: 刘双苔, 陈小艳, 王婷, 翁鸿, 刘同族, 李胜.  Bax蛋白表达与中国人群前列腺癌风险相关性的Meta分析【J】. 中国医刊, 2017,52(08):55-58.

15: 陶珍霞, 陈小艳, 王婷, 曾冬梅, 李晓燕, 翁鸿, 李胜. Bcl-2蛋白表达与中国人群前列腺癌风险相关性的Meta分析【J】. 中国医刊, 2017,52(07):52-58.

16: 王婷, 陈平, 翁鸿, 刘同族, 李胜. 临床护理路径在良性前列腺增生手术患者中的应用效果Meta分析【J】. 现代泌尿生殖肿瘤杂志, 2017,9(03):177-182.

17: 李胜, 晏鑫, 郭梓鑫, 孟详喻, 黄静宇. 基于文献计量学的PBL教学法研究现状分析【J】. 中华医学教育探索杂志，2018,17(11):16-22.

18: 王锋, 田小丽, 马诗静, 龚䶮, 谢丛华. 绿色荧光蛋白标记的Lewis肺癌小鼠原位模型的建立及鉴定【J】. 武汉大学学报（医学版）, 2018,39(05):689-692+778.